跳转至内容
Merck
CN
  • Facilitation of serotonin signaling by SSRIs is attenuated by social isolation.

Facilitation of serotonin signaling by SSRIs is attenuated by social isolation.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2014-07-02)
Elyse C Dankoski, Kara L Agster, Megan E Fox, Sheryl S Moy, R Mark Wightman
摘要

Hypofunction of the serotonergic system is often associated with major depression and obsessive compulsive disorder (OCD). Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to treat these disorders, and require 3-6 weeks of chronic treatment before improvements in the symptoms are observed. SSRIs inhibit serotonin's transporter, and in doing so, increase extracellular serotonin concentrations. Thus, efficacy of SSRIs likely depends upon the brain's adaptive response to sustained increases in serotonin levels. Individual responsiveness to SSRI treatment may depend on a variety of factors that influence these changes, including ongoing stress. Social isolation is a passive, naturalistic form of chronic mild stress that can model depression in rodents. In this study, we examined how 20-day treatment with the SSRI citalopram (CIT) alters marble-burying (MB), open field behavior, and serotonin signaling in single- vs pair-housed animals. We used in vivo voltammetry to measure electrically evoked serotonin, comparing release rate, net overflow, and clearance. Pair-housed mice were significantly more responsive to CIT treatment, exhibiting reduced MB and facilitation of serotonin release that positively correlated with the frequency of electrical stimulation. These effects of CIT treatment were attenuated in single-housed mice. Notably, although CIT treatment enhanced serotonin release in pair-housed mice, it did not significantly alter uptake rate. In summary, we report that chronic SSRI treatment facilitates serotonin release in a frequency-dependent manner, and this effect is blocked by social isolation. These findings suggest that the efficacy of SSRIs in treating depression and OCD may depend on ongoing stressors during treatment.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
D -山梨醇, ≥98% (GC)
Sigma-Aldrich
氢溴酸, ACS reagent, 48%
Sigma-Aldrich
氢溴酸, reagent grade, 48%
Sigma-Aldrich
D -山梨醇, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D -山梨醇, 99% (GC)
Sigma-Aldrich
D -山梨醇, ≥98% (GC), Molecular Biology
Supelco
山梨醇, Pharmaceutical Secondary Standard; Certified Reference Material
USP
山梨醇, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
氢溴酸, 48 wt. % in H2O, ≥99.99%
Sigma-Aldrich
D -山梨醇, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
山梨醇, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
山梨醇 F 液 溶液, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
D -山梨醇, ≥98% (GC), BioXtra
Sigma-Aldrich
D -山梨醇, FCC, FG
Sigma-Aldrich
D -山梨醇, liquid, tested according to Ph. Eur.
Sigma-Aldrich
D -山梨醇, Vetec, reagent grade, 97%